107 related articles for article (PubMed ID: 24619677)
1. Intratumoral injection of BCG-CWS-pretreated dendritic cells following tumor cryoablation.
Kawamura N; Udagawa M; Fujita T; Sakurai T; Yaguchi T; Kawakami Y
Methods Mol Biol; 2014; 1139():145-53. PubMed ID: 24619677
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
3. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
4. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
[TBL] [Abstract][Full Text] [Related]
6. Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton.
Seya T; Matsumoto M; Tsuji S; Begum NA; Nomura M; Azuma I; Hayashi A; Toyoshima K
Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S13-21. PubMed ID: 11603865
[TBL] [Abstract][Full Text] [Related]
7. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.
Tsuji S; Matsumoto M; Takeuchi O; Akira S; Azuma I; Hayashi A; Toyoshima K; Seya T
Infect Immun; 2000 Dec; 68(12):6883-90. PubMed ID: 11083809
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
9. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
den Brok MH; Sutmuller RP; Nierkens S; Bennink EJ; Toonen LW; Figdor CG; Ruers TJ; Adema GJ
Cancer Res; 2006 Jul; 66(14):7285-92. PubMed ID: 16849578
[TBL] [Abstract][Full Text] [Related]
10. Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors.
Tong Y; Song W; Crystal RG
Cancer Res; 2001 Oct; 61(20):7530-5. PubMed ID: 11606390
[TBL] [Abstract][Full Text] [Related]
11. Increased survival and decreased tumor size due to intratumoral injection of ethanol followed by administration of immature dendritic cells.
Kumagi T; Akbar SM; Horiike N; Onji M
Int J Oncol; 2003 Oct; 23(4):949-55. PubMed ID: 12963973
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells.
von Meyenn F; Schaefer M; Weighardt H; Bauer S; Kirschning CJ; Wagner H; Sparwasser T
Immunobiology; 2006; 211(6-8):557-65. PubMed ID: 16920494
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.
Geiger JD; Hutchinson RJ; Hohenkirk LF; McKenna EA; Yanik GA; Levine JE; Chang AE; Braun TM; Mulé JJ
Cancer Res; 2001 Dec; 61(23):8513-9. PubMed ID: 11731436
[TBL] [Abstract][Full Text] [Related]
15. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells.
Song W; Levy R
Cancer Res; 2005 Jul; 65(13):5958-64. PubMed ID: 15994975
[TBL] [Abstract][Full Text] [Related]
17. Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.
Candido KA; Shimizu K; McLaughlin JC; Kunkel R; Fuller JA; Redman BG; Thomas EK; Nickoloff BJ; Mulé JJ
Cancer Res; 2001 Jan; 61(1):228-36. PubMed ID: 11196166
[TBL] [Abstract][Full Text] [Related]
18. Tumor immunotherapy using bone marrow-derived dendritic cells overexpressing Toll-like receptor adaptors.
Akazawa T; Shingai M; Sasai M; Ebihara T; Inoue N; Matsumoto M; Seya T
FEBS Lett; 2007 Jul; 581(18):3334-40. PubMed ID: 17601575
[TBL] [Abstract][Full Text] [Related]
19. The restoration of suppressed T cell activities induced by 7,12-dimethylbenz[a]anthracene with an anti-tumor immunomodulator, BCG-cell wall skeleton.
Yamashita U; Ikegami R; Hamaoka T
Gan; 1982 Oct; 73(5):783-9. PubMed ID: 6219910
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium bovis Bacillus Calmette-Guerin infects DC-SIGN- dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production.
Gagliardi MC; Teloni R; Giannoni F; Pardini M; Sargentini V; Brunori L; Fattorini L; Nisini R
J Leukoc Biol; 2005 Jul; 78(1):106-13. PubMed ID: 15845642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
